Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59

Immunology

Volumn 92, Issue 2, 1997, Pages 252-258

  Wijburg, O L C ^a   Heemskerk, M H M ^b,c   Boog, C J P ^b,d   Van Rooijen, N ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HOST RESISTANCE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MACROPHAGE FUNCTION; MALE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL; VIRUS IMMUNITY; VIRUS TITRATION;

EID: 0030859408     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00340.x     Document Type: Article

References (37)

1. VAN ROOIJEN N., WIJBURG O.L.C., VAN DEN DOBBELSTEEN G.P.J.M. & SANDERS A. (1996) Macrophages in host defense mechanisms. Curr Top Microbiol Immunol 210, 159.
2. KAUFMANN S.H.E. (1993) Immunity to intracellular bacteria. Annu Rev Immunol 11, 129.
3. BEN-NATHAN B., HUITINGA I., LUSTIG S., VAN ROOIJEN N. & KOBILER D. (1996) West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol 141, 459.
4. KARUPIAH G., BULLER R.M.L., VAN ROOIJEN N., DUARTE C.J. & CHEN J. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol 70, 8301.
5. ZISMAN B., WHEELOCK E.F. & ALLISON A.C. (1971) Role of macrophages and antibody in resistance of mice against yellow fever virus. J Immunol 107, 236.
6. QIAN Q., JUTILA M.A., VAN ROOIJEN N. & CUTLER J.E. (1994) Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol 152, 5000.
7. UNANUE E.R. & ALLEN P.M. (1987) The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236, 551.
8. DELEMARRE F.G.A., KORS N. & VAN ROOIJEN N. (1991) Elimination of spleen and of lymph node macrophages and its difference in the effect on the immune response to paniculate antigens. Immunobiology 182, 70.
9. VAN ROOIJEN N. (1992) Macrophages as accessory cells in the 'in vivo' humoral immune response: From processing of particulate antigens to regulation by suppression. Sem Immunol 4, 237.
10. DEBRICK J.E., CAMPBELL P.A. & STAERZ U.D. (1991) Macrophages as accessory cells for Class 1 MHC-restricted immune responses. J Immunol 147, 2846.
11. ZHOU F., ROUSE B.T. & HUANG L. (1992) Induction of cytotoxic T lymphocytes in vivo with protein entrapped in membranous vehicles. J Immunol 149, 1599.
12. WEINER L.P. (1973) Pathogenesis of demyelination induced by mouse hepatitis virus (JHM virus). Arch Neurol 28, 298.
13. WEGE H., SIDDELL S. & TER MEULEN V. (1982) The biology and pathogenesis of coronavirus. Curr Top Microbiol Immunol 99, 164.
14. HEEMSKERK M.H.M., SCHOEMAKER H.M., SPAAN W.J.M. & BOOG C.J.P. (1995) Predominance of MHC Class II-restricted cytotoxic T cells against mouse hepatitis virus A59. Immunology 84, 521.
15. WIJBURG O.L.C., HEEMSKERK M.H.M., SANDERS A. & VAN ROOIJEN N. (1996) Role of virus-specific CD4 + cytotoxic T cells in recovery from mouse hepatitis virus infection. Immunology 87, 34.
16. VAN ROOIJEN N. & SANDERS A. (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174, 83.
17. KOOLEN M.J.M., OSTERHAUS A.D.M.E.. VAN STEENIS G., HORZINEK M.C. & VAN DER ZEIJST B.A.M. (1982) Temperature-sensitive mutants of mouse hepatitis strain A59: isolation, characterization and neuropathogenic properties. Virology 125, 393.
18. SPAAN W.J.M., ROTTIER P.J.M., HORZINEK M.C. & VAN DER ZEIJST B.A.M. (1981) Isolation and identification of virus-specific mRNA's in cells infected with mouse hepatitis virus (MHV-A59). Virol. 108, 424.
19. KAERBER G. (1931) Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch Exp Pathol Pharmakol 162, 480.
20. STEINMAN R.M. (1991) The dendritic cell and its role in immunogenicity. Annu Rev Immunol 9, 271.
21. VAN ROOIJEN N., KORS N., KRAAL G. (1989) Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J Leuk Biol 45, 97.
22. COUTELIER J.P., VAN DER LOGT J.T.M., HEESSEN F.W.A., VINK A. & VAN SNICK J. (1988) Virally induced modulation of murine IgG antibody subclasses. J Exp Med 168, 2372.
23. JOLICOEUR P. & LAMONTAGNE L. (1994) Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3. J Immunol 153, 1318.
24. SMITH A.L., BOTTOMLY K. & WINOGRAD D.F. (1987) Altered splenic T cell function of Balb/cByJ mice infected with mouse hepatitis virus or sendai virus. J Immunol 138, 3426.
25. DE SOUZA M.S., SMITH A.L. & BOTTOMLY K. (1991) Infection of Balb/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic T cell proliferation and cytokine production. Lab Anim Sci 41, 99.
26. CASEBOLT D.B., SPALDING D.M., SCHOEB T.R. & LINDSEY J.R. (1987) Suppression of immune response induction in Peyer's patch lymphoid cells from mice infected with mouse hepatitis virus. Cell Immunol 109, 97.
27. DEMPSEY W.L., SMITH A.L. & MORAHAN P.S. (1986) Effect of inapparent murine hepatitis virus infections on macrophages and host resistance. J Leuc Biol 39, 559.
28. MUELLER D.L., JENKINS M.K. & SCHWARTZ R.H. (1989) Clonal expansion vs. functional clonal activation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7, 445.
29. BOORMAN G.A., LUSTER M.I., DEAN J.H. et al. (1982) Peritoneal macrophage alterations caused by naturally occurring mouse hepatitis virus. Am J Pathol 106, 110.
30. DE SOUZA M.S. & SMITH A.L. (1991) Characterization of accessory cell function during acute infection of Balb/cByJ mice with mouse hepatitis virus (MHV), strain JHM. Lab Anim Sci 41, 112.
31. COUTELIER J.P., GODFRAIND C., DVEKSLER G.S. et al. (1994) B lymphocyte and macrophage expression of carcinoembryonic antigen-related adhesion molecules that serve as receptors for murine coronavirus. Eur J Immunol 24, 1383.
32. ALLISON A.C. (1978) Macrophage inhibition of lymphocyte response. Immunol Rev 40, 3.
33. LAHMY C. & VIRELIZIER J.L. (1981) Prostaglandins as probable mediators of the suppression of antibody production by mouse hepatitis virus infection. Ann Immunol (Inst Pasteur) 132C, 101.
34. VIRELIZIER J.P., CHAN E.L. & ALLISON A.C. (1977) Immunosuppressive effects of lymphocyte (type II) and leucocyte (type I) interferon on primary antibody reponses in vivo and in vitro. Clin Exp Immunol 30, 299.
35. KARP C.L., WYSOCKA M., WAHL L.M. et al. (1996) Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228.
36. TRINCHIERI G. (1997) Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFNγ). Curr Opin Immunol 9, 17.
37. BIRON C.A. (1994) Cytokines in the generation of immune responses to, and resolution, virus infection. Curr Opin Immunol 6, 530.